SE9704405D0 - New syringe - Google Patents

New syringe

Info

Publication number
SE9704405D0
SE9704405D0 SE9704405A SE9704405A SE9704405D0 SE 9704405 D0 SE9704405 D0 SE 9704405D0 SE 9704405 A SE9704405 A SE 9704405A SE 9704405 A SE9704405 A SE 9704405A SE 9704405 D0 SE9704405 D0 SE 9704405D0
Authority
SE
Sweden
Prior art keywords
chamber
less
protein
amino acid
stabilizer
Prior art date
Application number
SE9704405A
Other languages
English (en)
Swedish (sv)
Inventor
Karin Engstroem
Ebba Florin-Robertsson
Elvy Hoekby
Ulf Nilsson
Anders Stroem
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9704405A priority Critical patent/SE9704405D0/xx
Publication of SE9704405D0 publication Critical patent/SE9704405D0/xx
Priority to MXPA00005214A priority patent/MXPA00005214A/es
Priority to HU0004410A priority patent/HUP0004410A3/hu
Priority to RU2000116647/14A priority patent/RU2214285C2/ru
Priority to SK720-2000A priority patent/SK285668B6/sk
Priority to DE69837159T priority patent/DE69837159T2/de
Priority to EP98957272A priority patent/EP1034007B1/de
Priority to JP2000522963A priority patent/JP4564652B2/ja
Priority to PT98957272T priority patent/PT1034007E/pt
Priority to DK98957272T priority patent/DK1034007T3/da
Priority to AU13566/99A priority patent/AU742494B2/en
Priority to CZ20001948A priority patent/CZ300255B6/cs
Priority to AT98957272T priority patent/ATE354390T1/de
Priority to CA002311754A priority patent/CA2311754C/en
Priority to CNB988115921A priority patent/CN1156315C/zh
Priority to PCT/SE1998/002096 priority patent/WO1999027983A1/en
Priority to ES98957272T priority patent/ES2281142T3/es
Priority to NZ505150A priority patent/NZ505150A/xx
Priority to PL340731A priority patent/PL193243B1/pl
Priority to KR1020007005756A priority patent/KR100567358B1/ko
Priority to US09/196,514 priority patent/US6152897A/en
Priority to NO20002754A priority patent/NO324692B1/no
Priority to HK01103571A priority patent/HK1032920A1/xx
Priority to CY20071100395T priority patent/CY1106403T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9704405A 1997-11-28 1997-11-28 New syringe SE9704405D0 (sv)

Priority Applications (24)

Application Number Priority Date Filing Date Title
SE9704405A SE9704405D0 (sv) 1997-11-28 1997-11-28 New syringe
KR1020007005756A KR100567358B1 (ko) 1997-11-28 1998-11-19 0.5밀리리터 미만의 부피를 투여하기 위한, 동결건조된단백질 조성물을 포함하는 일회 투여용 주사기
AU13566/99A AU742494B2 (en) 1997-11-28 1998-11-19 A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml
AT98957272T ATE354390T1 (de) 1997-11-28 1998-11-19 Verfahren zur herstellung einer einzeldosisspritze mit lyophilisierter proteinmischung zur verabreichung eines volumens von weniger als 0,5 ml
RU2000116647/14A RU2214285C2 (ru) 1997-11-28 1998-11-19 Композиция для использования в однодозовом шприце
SK720-2000A SK285668B6 (sk) 1997-11-28 1998-11-19 Spôsob výroby jednodávkovej striekačky obsahujúcej lyofilizovaný proteín na podávanie objemu menšieho ako 0,5 ml
DE69837159T DE69837159T2 (de) 1997-11-28 1998-11-19 Verfahren zur herstellung einer einzeldosisspritze mit lyophilisierter proteinmischung zur verabreichung eines volumens von weniger als 0,5 ml
EP98957272A EP1034007B1 (de) 1997-11-28 1998-11-19 Verfahren zur herstellung einer einzeldosisspritze mit lyophilisierter proteinmischung zur verabreichung eines volumens von weniger als 0,5 ml
JP2000522963A JP4564652B2 (ja) 1997-11-28 1998-11-19 ０．５ｍｌ未満の容量を投与するための凍結乾燥タンパク質組成物を含む１回量注射器
PT98957272T PT1034007E (pt) 1997-11-28 1998-11-19 Método para a produção de uma seringa de dose única, contendo uma composição de proteina liofilizada, para a administração de um volume inferior a 0, 5 ml
DK98957272T DK1034007T3 (da) 1997-11-28 1998-11-19 Fremgangsmåde til fremstilling af en enkeltdosisspröjte omfattende en frysetörret proteinsammensætning til indgivelse af et volumen mindre end 0,5 ml
MXPA00005214A MXPA00005214A (es) 1997-11-28 1998-11-19 Una jeringa de una dosis, que comprende una composicion de proteina liofilizada, para administrar un volumen menor de 0.5 ml.
CZ20001948A CZ300255B6 (cs) 1997-11-28 1998-11-19 Zpusob prípravy jednorázové injekcní stríkacky
HU0004410A HUP0004410A3 (en) 1997-11-28 1998-11-19 A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0,5ml
CA002311754A CA2311754C (en) 1997-11-28 1998-11-19 A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml
CNB988115921A CN1156315C (zh) 1997-11-28 1998-11-19 包含冷冻干燥的蛋白组合物、给药体积小于0.5ml的单剂量注射器
PCT/SE1998/002096 WO1999027983A1 (en) 1997-11-28 1998-11-19 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml
ES98957272T ES2281142T3 (es) 1997-11-28 1998-11-19 Procedimiento de produccion de una jeringa monodosis, que comprende una composicion de proteina secada por congelacion para la administracion de un volumen inferior a 0,5 ml.
NZ505150A NZ505150A (en) 1997-11-28 1998-11-19 A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml
PL340731A PL193243B1 (pl) 1997-11-28 1998-11-19 Sposób wytwarzania jednodawkowej strzykawki
US09/196,514 US6152897A (en) 1997-11-28 1998-11-20 Syringe
NO20002754A NO324692B1 (no) 1997-11-28 2000-05-29 Engangs-sproyte
HK01103571A HK1032920A1 (en) 1997-11-28 2001-05-23 A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml.
CY20071100395T CY1106403T1 (el) 1997-11-28 2007-03-20 Μεθοδος για την παραγωγη μιας συριγγας μιας δοσης, που πepιλαμβανει μια ξηρανθεισα μεσω ψυξης συνθεση πρωτεϊνης, για τη χορηγηση ενος ογκου λιγοτepου απο 0,5 ml

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704405A SE9704405D0 (sv) 1997-11-28 1997-11-28 New syringe

Publications (1)

Publication Number Publication Date
SE9704405D0 true SE9704405D0 (sv) 1997-11-28

Family

ID=20409182

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704405A SE9704405D0 (sv) 1997-11-28 1997-11-28 New syringe

Country Status (24)

Country Link
US (1) US6152897A (de)
EP (1) EP1034007B1 (de)
JP (1) JP4564652B2 (de)
KR (1) KR100567358B1 (de)
CN (1) CN1156315C (de)
AT (1) ATE354390T1 (de)
AU (1) AU742494B2 (de)
CA (1) CA2311754C (de)
CY (1) CY1106403T1 (de)
CZ (1) CZ300255B6 (de)
DE (1) DE69837159T2 (de)
DK (1) DK1034007T3 (de)
ES (1) ES2281142T3 (de)
HK (1) HK1032920A1 (de)
HU (1) HUP0004410A3 (de)
MX (1) MXPA00005214A (de)
NO (1) NO324692B1 (de)
NZ (1) NZ505150A (de)
PL (1) PL193243B1 (de)
PT (1) PT1034007E (de)
RU (1) RU2214285C2 (de)
SE (1) SE9704405D0 (de)
SK (1) SK285668B6 (de)
WO (1) WO1999027983A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060157507A1 (en) * 2004-12-30 2006-07-20 Chang Byeong S Multi-functional container closure delivery system
US7959600B2 (en) 2004-12-30 2011-06-14 Byeong S. Chang Container closure delivery system
US20060144869A1 (en) * 2004-12-30 2006-07-06 Chang Byeong S Container closure delivery system
US8062254B2 (en) * 2008-01-08 2011-11-22 MacLean, LLC Spring driven adjustable oral syringe
CA2824390C (en) 2011-01-10 2016-03-08 Byeong Seon Chang Compact medication reconstitution device and method
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
KR102276304B1 (ko) 2013-09-27 2021-07-14 한미약품 주식회사 지속형 인간 성장 호르몬 제제
CN106999349A (zh) 2014-09-09 2017-08-01 拜昂·塞翁·常 溶液输送设备和方法
WO2018101358A1 (ja) * 2016-11-29 2018-06-07 Ｓｐｉｂｅｒ株式会社 タンパク質組成物、その製造方法及び熱安定性向上方法
CN108498467B (zh) * 2018-05-21 2019-03-05 中山未名海济生物医药有限公司 注射用重组人生长激素无菌粉末及其制备方法
IL272145A (en) * 2020-01-20 2021-07-29 Stem Cell Medicine Ltd Cosmetic preparations with protein concentrate from a conditioned growth medium of stem cells from adipose tissue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
JP3108077B2 (ja) * 1989-06-08 2000-11-13 住友製薬株式会社 製剤投与器
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5158546A (en) * 1991-08-07 1992-10-27 Habley Medical Technology Corp. Controlled action self-mixing vial
US5281198A (en) * 1992-05-04 1994-01-25 Habley Medical Technology Corporation Pharmaceutical component-mixing delivery assembly
SE9202108D0 (sv) * 1992-07-07 1992-07-07 Kabi Pharmacia Ab Dual-chamber injection cartridge
CA2337745C (en) * 1992-07-31 2005-04-12 Genentech, Inc. Human growth hormone aqueous formulation
US5334162A (en) * 1993-03-15 1994-08-02 Eli Lilly And Company Cartridge assembly for a lyophilized compound forming a disposable portion of an injector pen and method for same
FR2752733B1 (fr) * 1996-09-05 1998-11-06 Inst Nat Sante Rech Med Dispositif permeable a base d'hydrogel contenant des cellules vivantes, et ses applications

Also Published As

Publication number Publication date
CA2311754A1 (en) 1999-06-10
DE69837159D1 (de) 2007-04-05
WO1999027983A1 (en) 1999-06-10
NZ505150A (en) 2002-08-28
KR20010032514A (ko) 2001-04-25
CY1106403T1 (el) 2011-10-12
NO324692B1 (no) 2007-12-03
HK1032920A1 (en) 2001-08-10
CA2311754C (en) 2007-12-18
EP1034007A1 (de) 2000-09-13
NO20002754D0 (no) 2000-05-29
JP2001524360A (ja) 2001-12-04
AU1356699A (en) 1999-06-16
EP1034007B1 (de) 2007-02-21
HUP0004410A3 (en) 2003-05-28
RU2214285C2 (ru) 2003-10-20
ATE354390T1 (de) 2007-03-15
CN1156315C (zh) 2004-07-07
AU742494B2 (en) 2002-01-03
PT1034007E (pt) 2007-04-30
KR100567358B1 (ko) 2006-04-04
CZ300255B6 (cs) 2009-04-01
DE69837159T2 (de) 2007-11-22
HUP0004410A2 (hu) 2001-04-28
PL193243B1 (pl) 2007-01-31
SK285668B6 (sk) 2007-06-07
US6152897A (en) 2000-11-28
PL340731A1 (en) 2001-02-26
DK1034007T3 (da) 2007-05-21
SK7202000A3 (en) 2001-05-10
JP4564652B2 (ja) 2010-10-20
CN1280511A (zh) 2001-01-17
NO20002754L (no) 2000-05-29
CZ20001948A3 (cs) 2001-04-11
MXPA00005214A (es) 2002-04-24
ES2281142T3 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
CY1106403T1 (el) Μεθοδος για την παραγωγη μιας συριγγας μιας δοσης, που πepιλαμβανει μια ξηρανθεισα μεσω ψυξης συνθεση πρωτεϊνης, για τη χορηγηση ενος ογκου λιγοτepου απο 0,5 ml
EA200101005A1 (ru) Высокоэффективные композиции, содержащие дигидроэрготамин
EA199900979A1 (ru) Композиции активированного протеина
CO5050325A1 (es) Composiciones que contienen acidos difosfonicos
KR890003400A (ko) 경비(經鼻)투여용 생리 활성 펩티드 분말 조성물(제제)
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
MY128629A (en) Stabilized interleukin 2
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
ATE176482T1 (de) Asp-b28-insulinkristalle
CA2254145A1 (en) Improved process to stabilize proteins
ES8505545A1 (es) Un procedimiento para producir un preparado de gamma-interferon estable
MY109309A (en) Improvements in or relating to somatostatins
JPS54147916A (en) Preparation of urokinase injection
RU2000116647A (ru) Однодозовый шприц, содержащий композицию лиофилизованного белка, для введения объема менее, чем 0,5 мл
KR900015749A (ko) 인터루킨-1제형
TR199902575T2 (xx) Peptitler, proteinler ve nükleik asitler için stabil farmasötik uygulama formu.
KR910005886A (ko) 안정화 백혈구 인터페론
Lippton et al. Prodepin: a new product of the adrenomedullin (ADM) gene has systemic vasodilator activity
CA2395438C (en) Dry compositions containing hydrophobic amino acid
JPS63225320A (ja) 抗体を含有する安定水性組成物
SU1702412A1 (ru) Способ моделировани недостаточности трипсина IN VIVo
ES2140327A1 (es) Ampolla para sustancias terapeuticas inyectables.
RU96109524A (ru) Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для иньекций
TH43906B (th) อินเทอร์ลูคิน 2 ที่ถูกทำให้เสถียรแล้ว